As a part of the new digital strategy, Novo Nordisk is establishing a network of Digital Innovation Hubs in the most active and vibrant health- ecosystems in the world. These hubs will be a key link with local, digital healthcare start-ups but also with different players of the innovation ecosystem. Together we will co-create solutions, amplify our purpose, and defeat diabetes and other serious chronic disease.
This is a 6-month co-creation program, bringing together innovative
startups and industry know-how to solve internal challenges. The
program is divided into 4 stage innovation funnel: Challenge mapping,
Start-up scouting and selection, Pilot and Scale
What is it for the startups applying:
Paid Pilot with Novo Nordisk
Opportunity to co-create, experiment and deploy solutions for Novo Nordisk business units.
Based on pilot outcomes potential commercial partnership with GBS Novo Nordisk.
Visibility & Exposure
Exposure to the global team, business units for collaboration opportunities and access to a network of decision-makers and innovators.
Access to Data
Access to data from GBS business units to test and co-innovate solutions.
Subject matter expert support in technology, industry, business and global expansion.
Startups with tested and proven products/solutions built on emerging technologies can apply.
We are open to meet founders with other ground-breaking solutions for us!
Last date to apply: 24 April 2023
In this use case we are looking for solutions through which we can increase the engagement, fun and learning-based training with content tailored to employees’ roles and tasks. We are inviting you to bring us “best-in-class” digital solutions to establish an engaging gamified learning experience for our employees all around the world.
You will be collaborating closely with our team of Subject Matter Experts to define the training content.
The training should take the employee 15 to 20 minutes and must include:
Selected startups will get the opportunity for Mentorship, do a paid POC, and explore Commercial Partnerships with Novo Nordisk.